Claim Missing Document
Check
Articles

Found 2 Documents
Search

PROFIL ASAM LAKTAT PENDERITA DIABETES MELLITUS TERKENDALI (KONTROL) DAN TIDAK TERKENDALI (KONTROL) Laily Indrayanti; Harjo Mulyono
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol 14, No 3 (2008)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v14i3.927

Abstract

Lactic acid is an intermediate product of carbohydrate metabolism. Increment of plasma lactic acid level usually correlated withaerobic metabolism defect which caused by hypoperfusion or hypoxia, that can be happened in DM (Diabetes Mellitus) patients. DiabetesMellitus is a risk factor of lactic acidosis. Determination of glycated Hb (HbA1c) is a parameter to monitor the blood glucose. The aimof this study is to compare the mean lactic acid level between uncontrolled and controlled DM) patients and their correlation betweenlactic acid and HbA1c level. The research carried out by cross sectional study which was done at the Clinical Pathology Laboratory ofSardjito Hospital between September–October 2007. Inclusion criteria of samples were diabetic patients who had HbA1c examination.Statistical analysis was done by independent t test and Pearson correlation test. Twenty one patients were included in this research.They were divided into two (2) groups, group I are those who had HbA1c ≤ 7%, they consist of 10 patients, group II are patients whohad HbA1c ≥ 7.1%, they consist 11 patients. The mean of lactic acid of group I was 1.85 mmol/L and group II was 1.74 mmol/L (p = 0.574). There wasn’t any significant correlation between HbA1c level and lactic acid. (r = -0.179, p = 0.437). The mean of lacticacid level in uncontrolled DM was lower than the controlled one but not significant, and there was no significant correlation betweenHbA1c level and lactic acid. It is suggested to continue this study but with larger sample to know the correlation between lactic acid andHbA1c in DM patients who had metformin therapy.
HIPERURISEMIA SEBAGAI FAKTOR RAMALAN PERJALANAN PENYAKIT (PROGNOSIS) GEJALA KLINIK STROK INFARK Fenty .; Harjo Mulyono; Siti Muchayat
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY Vol 16, No 3 (2010)
Publisher : Indonesian Association of Clinical Pathologist and Medical laboratory

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24293/ijcpml.v16i3.1034

Abstract

Infarction stroke is a leading cause mortality and disability in the world. Appropriate management of acute infarction stroke will be able to reduced morbidity and mortality of the disease. Many laboratory parameters which can be done for detecting risk of prognosticfactors, one of them is serum uric acid concentration. The aim of this study is to know if hyperuricemia is prognostic factor for clinicaloutcome in acute infarction stroke.A prospective cohort study was carried out, compare between two groups of exposed and non-exposedgroup. Subjects who meet inclusion and exclusion criteria was involved in the study. The exposed group was a group of acute infarctionstroke patients who exposed to hyperuricemia, in other hand, patient who do not have hyperuricemia was separated as the non-exposedgroup. Inception cohort was applied when patient admits to emergency unit during 48 hours of onset, age ≥ 40 years old, man orwoman, have signed informed consent are inclusion criteria. Gadjah Mada Stroke Scale and serum uric acid concentration was measured on admission. Patient with haemorhage stroke and who are taking medicine that cause decrease uric acid are excluded. Test of serum uric acid concentration was performed by using Vitros 250, dry chemistry system. Patients were followed up 7 days in Neurology Unitand the outcome were measured by evaluating a score of Gadjah Mada Stroke Scale. Prognostic factor hyperuricemia has RR= 2.159(95% CI: 0.684-6.816), p= 0.158 for outcome. Hyperuricemia is not be evident as prognostic factor in acute infarction stroke.